Results
|
1.
|
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. MedStar authors:
Year: 2016
Citation: - American Journal of Cardiovascular Drugs. 16(1):55-65, 2016 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Ballantyne CM, Barter PJ, Borgman M, Brewer HB, Herrman JP, Hu B, Kastelein JJ, Kataoka Y, Merkely B, Nicholls SJ, Nissen SE, Puri R, Uno K, Wolski K
|
|
2.
|
COVID-19 Pandemic: Cardiovascular Complications and Future Implications. [Review] MedStar authors:
Year: 2020
Citation: - American Journal of Cardiovascular Drugs. 2020 Jun 23
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Akhtar T, Amgai B, Bandyopadhyay D, Chakraborty S, Das A, Fonarow GC, Ghosh RK, Gupta M, Hajra A, Lavie CJ, Naidu SS, Pal I, Patel N
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes. [Review] MedStar authors:
Year: 2021
Citation: - American Journal of Cardiovascular Drugs. 21(5):499-512, 2021 Sep.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Bandyopadhyay D, Deedwania P, Fonarow GC, Ghosh RK, Gupta M, Hajra A, Kaul S, Klein A, Lavie CJ, Mamas M, Roddy E
|